CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGW
Should you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry.
CERo Therapeutics vs.
CERo Therapeutics (NASDAQ:CEROW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, community ranking, dividends, institutional ownership, valuation, analyst recommendations, media sentiment, profitability and earnings.
In the previous week, 180 Life Sciences had 1 more articles in the media than CERo Therapeutics. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for CERo Therapeutics. 180 Life Sciences' average media sentiment score of 1.38 beat CERo Therapeutics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.
CERo Therapeutics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.
Summary
180 Life Sciences beats CERo Therapeutics on 2 of the 2 factors compared between the two stocks.
Get CERo Therapeutics News Delivered to You Automatically
Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CEROW vs. The Competition
CERo Therapeutics Competitors List
Related Companies and Tools
This page (NASDAQ:CEROW) was last updated on 2/22/2025 by MarketBeat.com Staff
Free CEROW Stock Alerts